Clinical Trial Update: NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI) [NA]

View source ↗

Summary

This clinical trial update describes the NATURE study evaluating EnVast as an adjunct to primary PCI in patients with ST-segment elevation myocardial infarction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• EnVast

Snippet

Sponsor: Vesalio | Conditions: Segment Elevation Myocardial Infarction (STEMI) | NA | Status: ACTIVE_NOT_RECRUITING